SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry

Eur J Cancer. 2021 Feb:144:382-385. doi: 10.1016/j.ejca.2020.11.015. Epub 2020 Nov 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology*
  • COVID-19 / immunology
  • COVID-19 / therapy
  • Female
  • Germany / epidemiology
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects
  • Immune Checkpoint Inhibitors / therapeutic use*
  • Male
  • Melanoma / drug therapy*
  • Melanoma / epidemiology
  • Melanoma / immunology
  • Middle Aged
  • Prognosis
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*
  • Registries
  • Risk Assessment
  • Risk Factors
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / epidemiology
  • Skin Neoplasms / immunology

Substances

  • Immune Checkpoint Inhibitors
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor